Company profile: CerSci Therapeutics
1.1 - Company Overview
Company description
- Provider of non-opioid medicines for acute and chronic pain, developing CT-044 with FDA-approved IND to proceed to Phase I safety and tolerability clinical trials; a non-opioid drug development firm based in Dallas, Texas.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CerSci Therapeutics
Caraway Therapeutics
HQ: United States
Website
- Description: Provider of precision small-molecule therapeutics for CNS and rare diseases, developing medicines that enhance cellular clearance by activating the lysosome to remove toxic materials and defective cellular components. Leverages modulation of mitophagy and autophagy to use natural clearance pathways, preventing cell damage and treating neurodegenerative disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caraway Therapeutics company profile →
Karuna Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical medicines for psychiatric and neurological conditions, developing treatments with a focus on schizophrenia and the behavioral symptoms of Alzheimer's.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Karuna Therapeutics company profile →
Drug Abuse Sciences
HQ: United States
Website
- Description: Provider of therapies for alcohol and drug addictions, offering Naltrexone Depot, a sustained-release formulation of naltrexone for alcohol and opiate addictions; DAS-431 for cocaine addiction; and Buprenorphine Depot, a sustained-release formulation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Drug Abuse Sciences company profile →
Sapiens
HQ: Germany
Website
- Description: Provider of medical device solutions for deep brain stimulation (DBS) therapy, developing a unique, high-resolution, MRI-compatible DBS system intended to improve patient comfort and therapeutic outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sapiens company profile →
Seelos Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapeutics, including: SLS-002 intranasal ketamine for acute suicidal ideation/behavior in MDD and PTSD; SLS-005 IV trehalose for ALS and spinocerebellar ataxia; SLS-009 targeting mutant/misfolded proteins in Huntington’s and Alzheimer’s via autophagy; SLS-004 SNCA gene therapy for Parkinson’s; SLS-007 peptide targeting alpha-synuclein aggregation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seelos Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CerSci Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CerSci Therapeutics
2.2 - Growth funds investing in similar companies to CerSci Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CerSci Therapeutics
4.2 - Public trading comparable groups for CerSci Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →